(Q34463433)

2 August 2017

title

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients (English)

1 reference

2 August 2017

0 references

0 references

2

Adrian C Covic

1 reference

2 August 2017

5

Anjay Rastogi

1 reference

2 August 2017

6

Bruce Spinowitz

1 reference

2 August 2017

9

Laura J Lisk

1 reference

2 August 2017

Jürgen Floege

1

1 reference

2 August 2017

Markus Ketteler

3

1 reference

2 August 2017

Johannes F E Mann

4

1 reference

2 August 2017

Edward M F Chong

7

1 reference

2 August 2017

Sylvain Gaillard

8

1 reference

2 August 2017

Stuart M Sprague

10

1 reference

2 August 2017

Sucroferric Oxyhydroxide Study Group

11

1 reference

2 August 2017

language of work or name

English

0 references

publication date

16 February 2015

1 reference

Nephrology Dialysis Transplantation

2 August 2017

published in

1 reference

2 August 2017

volume

30

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1037-1046

1 reference

Creative Commons Attribution-NonCommercial 4.0 International

2 August 2017

copyright license

start time

28 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Serum phosphorus levels and pill burden are inversely associated with adherence in patients on hemodialysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): evaluation of possible confounding by nutritional status

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

The roles of the skeleton and phosphorus in the CKD mineral bone disorder

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Phosphorus binders and survival on hemodialysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4438742

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFV006

Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFV006

Use of phosphate-binding agents is associated with a lower risk of mortality

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FNDT%2FGFV006

PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25691681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Challenge of phosphorus control in hemodialysis patients: a problem of adherence?

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25691681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25691681

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NDT/GFV006

1 reference

2 August 2017

1 reference

2 August 2017

1 reference